Lv41
440 积分 2024-03-04 加入
Translational medicine in China: Awareness is increasing and research is advancing
6天前
已关闭
Unraveling the autoimmune translational research process layer by layer
6天前
已完结
TNBC molecular subtypes and potential detection targets for biological therapy indications
12天前
已完结
Recent advancements in biomarkers and molecular diagnostics in hormonal receptor‐positive breast cancer
12天前
已完结
The present and future of PI3K inhibitors for cancer therapy
13天前
已完结
Artificial intelligence improves breast cancer detection in mammography screening
13天前
已完结
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer
19天前
已完结
Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
21天前
已完结
Beyond PI3Ks: targeting phosphoinositide kinases in disease
23天前
已完结
Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises
23天前
已完结
皖公网安备34019202002308
